Frequency of Myocardial Bridging in Patients With Coronary Artery Disease Undergoing CT Angiography
DOI:
https://doi.org/10.54112/bcsrj.v6i4.1668Keywords:
Coronary artery disease, myocardial bridging, CT coronary angiography, atherosclerosis, Pakistan, prevalenceAbstract
Coronary artery disease (CAD) is a major cause of morbidity and mortality in South Asia, including Pakistan. Myocardial bridging (MB), a condition where a coronary artery tunnels through the myocardium, has been linked to myocardial ischemia and arrhythmias. This study aimed to determine the prevalence of MB in patients with atherosclerotic CAD undergoing CT coronary angiography in a tertiary care hospital in Pakistan. Methods: Chaudhry Pervaiz Elahi Institute of Cardiology, Multan, conducted a descriptive cross-sectional study from July to December 2024. A total of 181 patients aged 40–70 years with a clinical diagnosis of atherosclerotic CAD were enrolled. Myocardial bridging was assessed using 64-slice multi-detector CT angiography. Data were analyzed using SPSS version 25, and associations between clinical variables and MB were determined using Chi-square tests. Results: The mean age of participants was 57.3 ± 8.1 years, with a male predominance (56.9%). Hypertension was the most common comorbidity (64.6%). Myocardial bridging was detected in 18 patients (9.9%), with the mid-segment of the left anterior descending (LAD) artery being the most commonly involved (77.8%). No significant associations were found between MB and clinical risk factors (p > 0.05). Conclusion: Myocardial bridging was present in 9.9% of CAD patients, with the mid-LAD segment being most commonly affected. Given the diagnostic accuracy of CT coronary angiography, its use in CAD assessments may aid in detecting this clinically significant anomaly.
Downloads
References
Sherin A, Khan MA, Ali A, Ahmed M, Iqbal N. Prevalence of cardiovascular risk factors in Pakistan: a cross-sectional study in rural and urban populations. BMJ Open. 2021;11(2):e040912.
Jafar TH, Gandhi M, de Silva HA, et al. Heart disease epidemic in Pakistan: current status and future directions. Lancet Reg Health Southeast Asia. 2022;3:100044.
Wang H, Zhao Y, Zhang X, Ma H, Zhang M, Li J. Myocardial bridging: a meta-analysis of its prevalence and clinical relevance. Int J Cardiol. 2021;339:113118.
Iannaccone M, D’Ascenzo F, Bertaina M, et al. Myocardial bridging and clinical outcome: a meta-analysis. Eur Heart J Cardiovasc Imaging. 2020;21(4):408–415.
Wang Y, Huang Y, Lu Y, Wu C, Liu J. Detection of myocardial bridging by coronary CT angiography and its relationship with coronary atherosclerosis. J Thorac Dis. 2019;11(4):1466–1473.
Al-Sadawi M, Ginter PS, Basnet S, et al. Myocardial bridging and its association with coronary artery disease: a comprehensive review. Curr ProblCardiol. 2022;47(3):100921.
Sorajja P, Ommen SR, Nishimura RA, et al. Myocardial bridging: diagnosis and management considerations. Am J Med. 2020;133(6):656–661.
Erkilic E, Turer AT, Kocaoglu M, et al. Clinical significance of myocardial bridging: Is it still a benign anomaly? Anatol J Cardiol. 2021;25(1):38–43.
Habib R, Asghar M, Hafeez M, et al. Frequency of myocardial bridging in Pakistani patients undergoing CT coronary angiography. Pak Heart J. 2020;53(2):113–117.
Windecker S, Kolh P, Alfonso F, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87–165.
Möhlenkamp S, Hort W, Ge J, Erbel R. Update on myocardial bridging. Circulation. 2021;144(3):160–172.
Wang H, Zhao Y, Zhang X, Ma H, Zhang M, Li J. Myocardial bridging: a meta-analysis of its prevalence and clinical relevance. Int J Cardiol. 2021;339:113118.
Al-Sadawi M, Ginter PS, Basnet S, et al. Myocardial bridging and its association with coronary artery disease: a comprehensive review. Curr ProblCardiol. 2022;47(3):100921.
Habib R, Asghar M, Hafeez M, et al. Frequency of myocardial bridging in Pakistani patients undergoing CT coronary angiography. Pak Heart J. 2020;53(2):113–117.
Erkilic E, Turer AT, Kocaoglu M, et al. Clinical significance of myocardial bridging: Is it still a benign anomaly? Anatol J Cardiol. 2021;25(1):38–43.
Berry JF, von Mering GO, Schmalfuss C, Hill JA, Kerensky RA. A CT angiography study shows that atherosclerotic plaque development is decreased in myocardial bridging segments. J Am Coll Cardiol. 2020;75(3):305–312.
Iannaccone M, D’Ascenzo F, Bertaina M, et al. Myocardial bridging and clinical outcome: a meta-analysis. Eur Heart J Cardiovasc Imaging. 2020;21(4):408–415.
Sorajja P, Ommen SR, Nishimura RA, et al. Myocardial bridging: diagnosis and management considerations. Am J Med. 2020;133(6):656–661.
Ertas F, Celik S, Tekin G, et al. The effect of myocardial bridging on coronary atherosclerosis: a computed tomography angiography study. Coron Artery Dis. 2022;33(1):15–20.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Komal Mushtaq, Nazahat Pasha, Umama Zafar

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.